Clinical Trials Sponsored by Institute of Infectious Disease, University of Cape Town

Total 787 results

Temple University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Wells and Enteric Disease Transmission (WET)

Diarrhea | Respiratory Viral Infection | Gastrointestinal Infection | Waterborne Diseases

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

HIV Prevention

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Immunologic Responses to a Live Attenuated Oral Cholera Vaccine

Cholera

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation

Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes

Covid19

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases

Dengue | Chikungunya | Zika | Aedes-borne Diseases

Mexico
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine

Meningitis

Mali
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

Herpes Zoster

United States
National Institute of Allergy and Infectious Diseases...
Rockefeller University

Withdrawn

Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI

HIV Infections

United States
Duke University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers

HIV Seropositivity | Lung Inflammation

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age (SLVP016)

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)

Influenza
Columbia University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study) (ENRICH)

HIV | Tuberculosis

Ethiopia
Yale University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes

Leishmaniasis

Colombia
Yale University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Expression of Mif Alleles in Individuals With Leishmaniasis

Leishmaniasis

Colombia
Laval University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Development and Optimization of a GBS Diagnostic Test

Streptococcus Group B

Canada
National Institute of Allergy and Infectious Diseases...
Emory University

Completed

Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)

Influenza A Virus, H5N1 Subtype

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)

Influenza

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Systems Biology of PNEUMOVAX®23 and PREVNAR 13®

Pneumococcal Infection

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012

Influenza
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)

Influenza
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013

Influenza
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Human Mucosal Immune Responses to Influenza Virus (SLVP026)

Influenza
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immune Memory After Papillomavirus Vaccination (IMAP-1)

Healthy Volunteers

United States
Tufts University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Transmission and the Respiratory Tract in Cryptosporidiosis

Cryptosporidiosis

Uganda
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots (HOME-1)

HIV Prevention | HIV Treatment

United States
University of Wisconsin, Madison
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

GRoup A StrePtococcus (GRASP)

Streptococcal Pharyngitis

United States
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Novel Approaches for Quantitative Assessment of Adherence (Tracer Pilot)

Healthy

United States
University of New Mexico
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Hantavirus Transmission in Households in Chile

Hantavirus Infections

Chile
NeoImmuneTech
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Terminated

A Trial of NT-I7 in COVID-19 (SPESELPIS)

COVID-19

United States
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Persistence of Protection by Shingrix

Herpes Zoster

United States
University of Maryland, Baltimore
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection

Salmonella

United States
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses

Pneumococcal Infections | HIV | Pneumococcal Vaccines

United States
University of New Mexico
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome

Hantavirus Infections

Chile
Yale University
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Cali Sin Tos Aim 2

Tuberculosis

Colombia
Duke University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Pneumonia Direct Pilot (PDP)

Pneumonia, Bacterial | Ventilator Associated Pneumonia

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Understanding COVID-19 Vaccine Immunity in Tissue and Blood

COVID-19 (Coronavirus Disease 2019)

United States
Yale University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Systems Investigation of Vaccine Responses in Aging and Frailty

Influenza

United States
Yale University
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

mHealth HIV Prevention for Transgender Women

HIV

Malaysia
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Systems Biology of Zoster Vaccine

Zoster | Zoster Varicella | Shingles | Chicken Pox

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort (SLVP033)

Hepatitis A | Influenza | Healthy Adults | Typhoid

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation

Characterization of Human Memory Immune Responses to Prior Yellow Fever Vaccination

Yellow Fever Vaccine

United States
Duke University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Multi-Drug Resistant Organism Network (MDRO Network)

Bacterial Infections | Infections Resistant to Multiple Drugs

China, United States, Australia, Colombia
Columbia University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

FluSAFE: Flu SMS Alerts to Freeze Exposure

Influenza | Acute Respiratory Infection | Influenza-like Illness

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response (HIPCVAX-010S)

Influenza A Subtype H5N1 Infection

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection (SLVP030)

Healthy | Influenza

United States
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Hepatitis C

United States
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Yellow Fever Immune Response at Single Cell Resolution

Healthy

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery (POISED)

Peanut Allergy

United States

Clinical Trials Sponsored by Institute of Infectious Disease, University of Cape Town

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations